We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
80 hedge funds and large institutions have $512M invested in Oric Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
41% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 22
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
2% less funds holding
Funds holding: 82 → 80 (-2)
4.11% less ownership
Funds ownership: 92.63% → 88.52% (-4.1%)
33% less capital invested
Capital invested by funds: $762M → $512M (-$250M)
Holders
80
Holders Change
-2
Holders Change %
-2.44%
% of All Funds
1.23%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
31
Reduced
22
Closed
12
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
–
Top Buyers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$10.1M |
| 2 |
Alkeon Capital Management
New York
|
+$6.7M |
| 3 |
SCM
Suvretta Capital Management
New York
|
+$4.55M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$4.04M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.3M |
